The advanced lung cancer inflammation index (ALI), which includes BMI, albumin, and neutrophil to lymphocyte ratio (NLR), was initially developed for lung cancer (19–22), but has since been applied to other cancers including esophageal, pancreatic, and gastric cancers (17, 23–25). This evidence concerns the gene ALB and lung cancer.